FDA Clearance Tracker · P030031-S142
THERMOCOOL SMARTTOUCH® SF Catheter
Last checked: Nov 20, 2026Latest source record: Sep 2, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 2, 2026
Approved
Time to decision
180 days
Received Mar 6, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030031-S142
- Device name
- THERMOCOOL SMARTTOUCH® SF Catheter
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Mar 6, 2026
- Decided
- Sep 2, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030031
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
The Biosense Webster THERMOCOOL SMARTTOUCH SF Uni-/Bi-DirectionalNavigation Catheter and related accessory devices are indicated for catheter-based cardiac electrophysiological mapping (stimulating and recording) and, when used with a compatible RF generator, for the treatment of: Type I atrial flutter in patients age 18 or older. Recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems, as an alternative to antiarrhythmic drug therapy, or as an initial rhythm control strategy. Drug refractory recurrent symptomatic persistent atrial fibrillation (defined as continuous atrial fibrillation that is sustained beyond 7 days but less than 1 year), refractory or intolerant to at least one Class I or III antiarrhythmic medicine, when used with compatible three-dimensional electroanatomic mapping systems.The Biosense Webster THERMOCOOL SMARTTOUCH SF Uni-/Bi-DirectionalNavigation Catheter provides a real-time measurement of contact force between the catheter tip and the heart wall, as well as location information when used with the CARTO 3 System.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.